Top list · United States
540 pharma startups in the United States have raised money in rounds we track. These are the 50 that have raised the most, $23B between them, with New York the most common home.
Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.
Founded 2021San Francisco, United States$3.0Blast round Sept 2021Retro Biosciences is a biotechnology company based in Redwood City, California, founded in May 2021.
Founded 2021Redwood City, United States$1.2Blast round May 2026Resilience is a cyber risk company based in San Francisco, founded in 2016 by experts from military intelligence, insurance, and technology.
Founded 2016New York, United States$860Mlast round Oct 2025Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Founded 2019Radnor, United States$788Mlast round Jun 2026Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Founded 2019Waltham, United States$719Mlast round Mar 2026Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Founded 2013San Carlos, United States$633Mlast round Jan 2026Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.
Founded 2012New York, United States$577Mlast round May 2025CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
Founded 2014United States$550Mlast round Mar 2026Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.
Founded 2018New York, United States$550Mlast round Dec 2025Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Founded -Waltham, United States$530Mlast round Sept 2026MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Founded 2018Palo Alto, United States$523Mlast round Aug 2026Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023.
Founded -Austin, United States$430Mlast round Jun 2026Remedi SeniorCare provides pharmacy services by offering automatic therapeutic interchange education and consulting and transition services.
Founded 1954Baltimore, United States$430Mlast round Aug 2013Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Founded 2015Hayward, United States$427Mlast round Oct 2025Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Founded 2023Waltham, United States$420Mlast round Mar 2026SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Founded 2017Stamford, United States$400Mlast round Dec 2023Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.
Founded 2011Conshohocken, United States$350Mlast round Jul 202589bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Founded 2018San Francisco, United States$348Mlast round Jan 2025NGM Biopharmaceuticals Inc.
Founded 2008South San Francisco, United States$333Mlast round Mar 2015Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Founded 2014Burlingame, United States$310Mlast round Jan 2026Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Founded 2018South San Francisco, United States$300Mlast round Apr 2026Beeline Medicines is a clinical-stage biotechnology company based in Boston, Massachusetts, focused on developing precision therapies for autoimmune and inflamm
Founded 2025Stamford, United States$300Mlast round Apr 2026ACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies.
Founded 2020Los Angeles, United States$300Mlast round Sept 2022Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.
Founded 2012Redwood City, United States$294Mlast round Sept 2022Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other incurable diseases.
Founded 2015Redwood City, United States$285Mlast round Nov 2023Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Founded -Cambridge, United States$280Mlast round Apr 2024Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.
Founded 2018Chicago, United States$270Mlast round Nov 2022Capital Rx, now rebranded as Judi Health, is a prominent enterprise health technology company specializing in pharmacy benefits management (PBM).
Founded 2017New York, United States$264Mlast round Sept 2025Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Founded 2014Boston, United States$257Mlast round Aug 2025Kardigan is a heart health company developing drugs designed to make cardiovascular disease curable, preventable, and no longer the leading cause of death.
Founded 2023Princeton, United States$254Mlast round Oct 2025LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
Founded 2015Menlo Park, United States$250Mlast round Jul 2026ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Founded 2014South San Francisco, United States$248Mlast round May 2025Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Founded 2017Plymouth Meeting, United States$248Mlast round Oct 2024Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Founded 2016Westlake Village, United States$245Mlast round Feb 2024Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Founded 2023London, United States$245Mlast round Oct 2023Omni Metalcraft provides conveyors, replacement rollers, and components to manufacturing industries.
Founded 1976Alpena, United States$244Mlast round Nov 2026Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Founded 2024Boston, United States$240Mlast round Mar 2026Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Founded -New York, United States$236Mlast round Jun 2023Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients.
Founded -United States$230Mlast round Feb 2023Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Founded -Boston, United States$225Mlast round Sept 2026Moksha8 is a pharmaceutical company providing therapeutics for the treatment of central nervous system and mental health disorders.
Founded 2007Berwyn, United States$224Mlast round Oct 2012Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.
Founded 2021Cambridge, United States$220Mlast round Oct 2026Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.
Founded 2014San Diego, United States$217Mlast round Aug 2023Metsera operates as a clinical-stage biopharmaceutical company.
Founded 2022New York City, United States$215Mlast round Nov 2024Companies whose funding rounds we classed in this sector, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back pharma startups in the United States in the app, with filters, lists and exports.
DT
VPharma startups that raised in 2026198 companies · $10B in 2026
C
OT
APharma startups in the United Kingdom76 companies · $4.0B
DT
QPPharma startups founded in 201963 companies · $3.5B
AL
RB
MTPharma startups founded in 202160 companies · $6.3B
I
MT
8Pharma startups founded in 201858 companies · $4.5BNR
BTPharma startups founded in 202057 companies · $3.5B
IP
IT
VTPharma startups in France40 companies · $803M
M
LB
DTPharma startups founded in 202230 companies · $1.0B
O
A
XStartups in the United States42,176 companies · $870B
GV
V
RPHealth startups in the United States7,411 companies · $71B
O
A
XAI startups in the United States5,656 companies · $718B
V
RP
DHHealthcare startups in the United States4,148 companies · $51B
S
P
IIT Services startups in the United States3,482 companies · $27B
D
CE
ADBig Data & Analytics startups in the United States2,107 companies · $132B
O
A
WAI startups in the United States that raised in 20261,648 companies · $431B in 2026
D
P